ArticleAnnals of hematology2020

IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

Anna-Sophia Kattner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.